TCMBANKIN001683 |
cymarol |
|
C30H46O9 |
550.7 g/mol |
CC1C(C(CC(O1)OC2CCC3(C4CCC5(C(CCC5(C4CCC3(C2)O)O)C6=CC(=O)OC6)C)CO)OC)O |
TCMBANKIN011203 |
Cymarin |
cymarin |
C30H44O9 |
548.66 |
CC1C(C(CC(O1)OC2CCC3(C4CCC5(C(CCC5(C4CCC3(C2)O)O)C6=CC(=O)OC6)C)C=O)OC)O |
TCMBANKIN022339 |
strophanthidin-β-d-glucosyl-(1→4)-β-d-digita-loside |
|
C36H54O15 |
|
|
TCMBANKIN025619 |
(+)-Catechin-5-O-glucoside |
(2S,3R,4S,5S,6R)-2-[[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-5-chromanyl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-chroman-5-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxychroman-5-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; (+)-catechin-5-o-glucoside; (2S,3R,4S,5S,6R)-2-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-chroman-5-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-chroman-5-yl]oxy-6-methylol-tetrahydropyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-chroman-5-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; (?)-Epicatechin-5-O-beta-D-glucopyranoside |
C21H24O11 |
452.4 g/mol |
C1C(C(OC2=C1C(=CC(=C2)O)OC3C(C(C(C(O3)CO)O)O)O)C4=CC(=C(C=C4)O)O)O |
TCMBANKIN031916 |
alpha-amyrine lupeol |
|
|
0 |
|
TCMBANKIN032630 |
k-strophanthidin-beta |
|
|
0 |
|
TCMBANKIN036845 |
isoquercitrin |
BDBM84979; FT-0627504; ISOQUERCITRIN |
C21H20O12 |
464.376 |
C1(c2c([H])c([H])c(O[H])c(O[H])c2[H])=C(O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])C(=O)c4c(c([H])c(O[H])c([H])c4O[H])O1 |
TCMBANKIN038480 |
strophanthidin-beta-d-glucosyl-(1-4)-beta-d-digitaloside |
|
C36H54O15 |
|
|
TCMBANKIN039013 |
quercetin-3-o-[β-d-glucopyranosyl-(1→2)-β-d-glucopyranoside] |
|
C27H30O17 |
|
C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)OC5C(C(C(C(O5)CO)O)O)O)O)O)O |
TCMBANKIN039282 |
Apocynoside II |
|
|
402.4 g/mol |
|
TCMBANKIN039601 |
Neoisostegane |
|
|
414.4 g/mol |
|
TCMBANKIN041173 |
Strophanthidin-beta-D-digitaloside |
strophanthidin-β-d-digitaloside |
C30H44O10 |
|
C1([H])([H])C([H])([H])[C@@](C([H])=O)([C@@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C2=C([H])C(=O)OC2([H])[H])C([H])([H])C3([H])[H])[C@]34O[H])[C@@]4([H])C([H])([H])C5([H])[H])[C@@
]5(O[H])C([H])([H])[C@]1([H])O[C@@]6([H])[C@]([H])(O[H])[C@@]([H])(OC([H])([H])[H])[C@@]([H])(O[H])[C@@]([H])(C([H])([H])[H])O6 |
TCMBANKIN043360 |
Apocynol B |
|
|
240.29 g/mol |
|
TCMBANKIN047599 |
Apocynol A |
|
|
224.3 g/mol |
|
TCMBANKIN058130 |
quercetin-3-O-galactoside |
hyperin; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; SMR000466394; C10073; ACon1_000623; Quercetin 3-O-beta-D-galactopyranoside; Quercetin-3-O-galactoside;p Hyperin; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-; 482-36-0; Hyperin; Quercetin 3-galactoside; AIDS026341; Hyperasid; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; NSC 407304; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; Quercetin-3-O-galactoside; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; Hyperozide; AIDS-026341; MLS000759538; Quercetin 3-D-galactoside; EINECS 207-580-6; Quercetin-3-galactoside; Hyperin (8CI); Hyperoside; 2-(3,4-Dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one; 83388_FLUKA; MEGxp0_000392; Hyperosid; Quercetin 3-beta-D-galactopyranoside |
C21H19O12- |
463.4 g/mol |
C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)[O-] |
TCMBANKIN058213 |
kaemferol;kampferol;kaempferol;campherol |
TNP00039; nchembio.2007.28-comp30; Kaempherol; 5-18-05-00251 (Beilstein Handbook Reference); Prestwick2_001098; CHEBI:28499; Prestwick1_001098; CAS-520-18-3; BRN 0304401; Flavone, 3,4',5,7-tetrahydroxy-; ST030560; MEGxp0_001283; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4'-Trihydroxyflavonol; C.I. 75640; Swartziol; K0133_SIGMA; kaempferol oxoanion; NCGC00016480-01; 60010_FLUKA; EINECS 208-287-6; Pelargidenon; Nimbecetin; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4-chromenone; NSC 407289; 3,4',5,7-Tetrahydroxyflavone; HSCI1_000027; Pelargidenolon 1497; NSC407289; Robigenin; C05903; CPD1F-90; Kampferol; NSC 656277; Prestwick0_001098; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one; Populnetin; Kampcetin; Prestwick3_001098; AIDS-001404; ZINC00137345; kaempferol ; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-olate; 3,4′,5,7-Tetrahydroxyflavone; Rhamnolutein; NCGC00016480-02; ACon1_001867; NSC656277; 3,4′,5,7-Tetrahydroxyflavone; BSPBio_001176; SPBio_003058; Oprea1_650954; 5,7,4'-Trihydroxyflavonol; 4H-1-Benzopyran-4-one,3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4'-Trihydroxyflavonol; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- (9CI); Campherol; 520-18-3; 3,5,7-TRIHYDROXY-2-(4-HYDROXYPHENYL)-4H-CHROMEN-4-ONE; S00111; Trifolitin; Kampherol; AI3-36096; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromone; Indigo yellow; Pelargidenolon; AIDS001404; nchembio718-comp14; NCGC00091036-01; Flavone, 3,4',5,7-tetrahydroxy- (7CI,8CI); CHEBI:58573; Kaemferol; Kempferol; BPBio1_001294; 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Rhamnolutin; 3,5,7-triOH-Flavone; KMP; CCRIS 41; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- |
C15H10O6 |
286.24 g/mol |
C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O |
TCMBANKIN058215 |
kaempferol-3-o-beta-d-glucoside |
kaempferol-3-O-β-D-glucopyranoside;Kaempferol-3-glucoside;astragalin;Kaempferol-3-o- glucoside;kaempferol 3-glucoside;Kaempferol 3-O-glucoside;kaempferol-3-o-glucoside;5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl beta-D-glucopyranoside; Kaempferol-3-O-.beta.-D-glucopyranoside; Kaempferol-3-beta-glucopyranoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; NCGC00163580-01; 4H-1-Benzopyran-4-one, 3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-; Astragaline; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; Kaempferol-3-D-glucoside; 3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; MEGxp0_000168; Kaempferol-3-beta-monoglucoside; Kaempferol-3-O-glucoside; 3,4',5,7-Tetrahydroxyflavone-3-glucoside; 480-10-4; ACon1_001224; SCHEMBL23898; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; AIDS-051935; AIDS051935; CHEBI:30200; LMPK12111725; Kaempferol 3-O-beta-D-glucopyranoside; C12249; Astragalin; Kaempferol 3-O-glucoside; Kaempferol 3-glucoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; Kaempferol 3-O-beta-D-glucoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone;kaempferol-3-β-D-glucopyranoside;Kaempferol-3-O-β-D- glucopyranoside; kaempferol-3-o-beta-d-glucopyranoside;kaempferol-3-O-β-D-glucoside; Kaempferol-3-o-β-D- glucoside; Kaempferol- 3-O-β-D-glucoside |
C21H20O11 |
448.38 |
C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O |
TCMBANKIN058388 |
Morkit |
NCGC00094960-01; Anthracene, 9,10-dihydro-9,10-dioxo-; Anthraquinone [BSI:ISO]; PS926_SUPELCO; Spectrum4_000907; 9,10-Anthracendion; SPBio_000330; ZINC03847491; Hoelite; KBio2_007143; AIDS-001365; SpecPlus_000645; anthra-9,10-quinone; BSPBio_003141; 9,10-Anthracenedione; C16207; 45327_RIEDEL; KBio1_001685; SPECTRUM1502103; Corbit; DivK1c_006741; KBio2_002007; Caswell No. 052A; 9,10-Dioxoanthracene; A90004_ALDRICH; Spectrum5_001897; KBio2_004575; 790240-52-7; ANTHRAQUINONE; InChI=1/C14H8O2/c15-13-9-5-1-2-6-10(9)14(16)12-8-4-3-7-11(12)13/h1-8; CHEBI:40448; KBio3_002641; Anthrapel; 84-65-1; NCGC00094960-02; Spectrum2_000405; KBioSS_002007; 9,10-Anthrachinon; EINECS 201-549-0; Bis-alkylamino anthraquinone; NCGC00094960-03; CCRIS 649; NSC 7957; Anthrachinon; AI3-09073; NSC7957; ST5410412; Anthradione; HSDB 2074; KBioGR_001374; Spectrum_001527; EPA Pesticide Chemical Code 122701; 9,10-Anthrachinon [Czech]; 9,10-Anthraquinone; AIDS001365; Spectrum3_001501; anthracene-9,10-dione; AN-24075; Melting point standard 283-286 inverted exclamation markaC; MolPort-001-783-170; D0L5LN; BBL003001; Anthracene-9,10-quinone; KBio2_007143; MCULE-4655011423; KBio2_002007; LS-1837; Morkit; T8216; K513; ST24024605; 9,10-quinone; HMS1921J14; Anthraquinone 100 microg/mL in Acetonitrile; Bis-alkylamino anthraquinone; 9,10-Anthraguinone; Az-Q; Anthracene,10-dihydro-9,10-dioxo-; TRA0074021; Epitope ID:116191; Anthraquinone, purum, >=99.0% (HPLC); STK398385; anthracene-9,10-dione; SBB060613; Melting point standard 283-286C, analytical standard; AK117080; DSSTox_CID_95; Spectrum4_000907; Tox21_111369; UNII-030MS0JBDO; 9,10-Anthracendion; CAS-84-65-1; SpecPlus_000645; NCGC00094960-06; 9,10-Anthracenedione; 9,10-dihydro-9,10-dioxoanthracene; AC1Q6JY1; DSSTox_GSID_20095; Morkie; 9,10-dihydroanthracene-9,10-dione; KBio3_002641; 84-65-1; AB-131/40003277; KBioSS_002007; A0502; EINECS 201-549-0; CCRIS 649; SC-46775; Anthrachinon; BDBM50094892; HSDB 2074; KBioGR_001374; EPA Pesticide Chemical Code 122701; 9,10-Anthrachinon [Czech]; Tox21_111369_1; KBio2_004575; 9,10-anthrachinoe; Spectrum3_001501; NCGC00094960-01; SR-01000944707-1; ZINC3847491; TR-031315; Anthracene, 9,10-dihydro-9,10-dioxo-; Anthraquinone, 97%; KSC362C5J; Anthracenequinone; BSPBio_003141; Anthraquinone, analytical standard; Anthraquinone, Vetec(TM) reagent grade, 97%; AC-12719; SPECTRUM1502103; MFCD00001188; Caswell No. 052A; 030MS0JBDO; Spectrum5_001897; CHEBI:40448; InChI=1/C14H8O2/c15-13-9-5-1-2-6-10(9)14(16)12-8-4-3-7-11(12)13/h1-8; F0001-2133; Spectrum2_000405; NCGC00094960-02; RP26414; NCGC00094960-03; KB-74706; NSC 7957; DTXSID3020095; DS-4810; 9,10-Anthraquinone; I14-1219; RTR-031315; ST50410412; DB-005409; Anthraquinone [BSI:ISO]; FT-0622417; Anthra-9,10-quinone #; SPBio_000330; EC 201-549-0; Hoelite; NCGC00094960-04; Anthraquinone, PESTANAL(R), analytical standard; C16207; SCHEMBL14943; KBio1_001685; Corbit; AJ-45864; CHEMBL55659; DivK1c_006741; Anthra-9,10-quinone; DSSTox_RID_75364; BG01517201; 9,10-Dioxoanthracene; NSC-7957; ANTHRAQUINONE; Anthrapel; ACMC-209pw0; AC1L1NAG; SR-01000944707; 9,10-Anthrachinon; RZVHIXYEVGDQDX-UHFFFAOYSA-N; AI3-09073; NSC7957; Anthradione; Spectrum_001527; CCG-39966; AKOS000282964; ANW-37822; anthraquinone |
C14H8O2 |
208.21 |
C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2=O |
TCMBANKIN059280 |
glochidionionoside c |
apocynoside i |
C19H30O8 |
386.4 g/mol |
CC(C=CC1C(=CC(=O)CC1(C)C)COC2C(C(C(C(O2)CO)O)O)O)O |
TCMBANKIN059905 |
p-isopropyltoluene;4-Isopropyltoluene;cymene;1-methyl-4-(1-methylethyl)benzene;Cymol;Para cymene;4-Cymol;p-cymene;Dolcymene |
|
C10H14 |
134.22 g/mol |
CC1=CC=C(C=C1)C(C)C |
TCMBANKIN060106 |
Cynotoxin |
|
C23H32O6 |
404.5g/mol |
CC12CCC3C(C1(CCC2C4=CC(=O)OC4)O)CCC5(C3(CCC(C5)O)C=O)O |
TCMBANKIN060264 |
rutin |
|
C27H30O16 |
610.5 g/mol |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O |
TCMBANKIN060276 |
cymarose |
|
C7H14O4 |
|
CC1C(C(CC(O1)O)OC)O |